BB&T Securities’s DexCom DXCM Stock Holding History

BB&T Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.07M	Buy	28,800 +2,724	+10%	+$106K	0.01%	767
2019 Q2	$976K	Buy	26,076 +564	+2%	+$17.7K	0.01%	820
2019 Q1	$759K	Sell	25,512 -2,864	-10%	-$101K	0.01%	914
2018 Q4	$849K	Sell	28,376 -2,328	-8%	-$73.8K	0.01%	790
2018 Q3	$1.1M	Hold	30,704	–	–	0.01%	794
2018 Q2	$729K	Buy	30,704 +340	+1%	+$7.21K	0.01%	928
2018 Q1	$562K	Buy	30,364 +10,112	+50%	+$150K	0.01%	971
2017 Q4	$290K	Sell	20,252 -10,344	-34%	-$134K	﹤0.01%	1200
2017 Q3	$374K	Buy	30,596 +408	+1%	+$7.21K	0.01%	1078
2017 Q2	$552K	Sell	30,188 -240	-0.8%	-$4.43K	0.01%	940
2017 Q1	$644K	Sell	30,428 -6,772	-18%	-$132K	0.01%	805
2016 Q4	$815K	Hold	37,200	–	–	0.01%	678
2016 Q3	$815K	Buy	+37,200	New	+$828K	0.01%	677

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BB&T Securities's DXCM Position: Q3 2019 in Review

BB&T Securities increased its DexCom (DXCM) stake by 10% in Q3 2019, buying an estimated $106K and bringing the position to 28,800 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #767.

BB&T Securities first reported a position in DXCM in Q3 2016 and has held it in 13 quarters since. The position peaked at $1.1M in Q3 2018. 424 funds tracked by Wall St. Rank hold DXCM as of Q3 2019.

BB&T Securities held 28,800 shares of DexCom worth $1.07M as of Q3 2019.
BB&T Securities bought 2,724 DexCom shares in Q3 2019, an estimated $106K.
DexCom made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #767 holding.
BB&T Securities first reported a position in DexCom in Q3 2016 and has held it in 13 quarters since.
BB&T Securities's DexCom position peaked at $1.1M in Q3 2018.
424 funds tracked by Wall St. Rank held DexCom as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.